Amgen declares $1.15 per share dividend
Health Care & Life Science, Latest news, TechnologyThe board of directors for Thousand Oaks biotechnology company Amgen declared a $1.15 per share dividend March 3 for the second quarter of 2017. The dividend will be paid on June 8 to all stockholders of record as of the close of business on May 17. The company has a market cap of $130.1 billion Read More →
Calavo Growers reports record revenues but net income down
Agribusiness, Earnings, Latest news, Tri-County Public CompaniesSanta Paula-based Calavo Growers reported record first quarter revenues of $226.6 million, up from $204.6 million a year ago, but net income fell to $5.2 million from $6.3 million a year ago. The revenue growth was fueled by the performance of Calavo’s fruit and vegetables company Renaissance Food Group, which showed a 29 percent rise Read More →
Interlink net income grows on higher revenues
Earnings, Latest news, Technology, Tri-County Public CompaniesStory updated at 11 a.m. March 6: Interlink Electronics reported a 67 percent year-over-year increase in net income March 3, bringing in $924,000 for the fourth quarter 2016 and $2.89 million for the year. Revenues were almost flat to the fourth quarter of 2015 at $2.78 million, while fiscal year revenues increased 13 percent to Read More →
Stellar Biotechnologies gets immunotherapy manufacturing contract
Earnings, Latest news, Technology, Tri-County Public Companies, West Ventura CountyPort Hueneme immunotherapy company Stellar Biotechnologies announced an exclusive multi-year supply agreement with Taiwanese manufacturer Amaran Biotechnology. The agreement coincides with late-stage clinical studies for an immunotherapy called Adagloxad Simolenin, which treats cancers including metastatic breast cancer. The two companies will also develop the manufacturing process for Stellar’s Keyhole Limpet Hemocyanin conjugated vaccine, made from Read More →
San Luis Obispo airport adds nonstop flight to Denver
Central Coast, middle, TourismThis article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Study shows Amgen’s Blincyto a better alternative than chemotherapy
Latest newsAmgen’s new leukemia drug Blincyto increases the length of survival among high-risk patients, according to a study released by the New England Journal of Medicine. Results from its Phase 3 Tower study revealed that Blincyto almost doubled median overall survival versus chemotherapy among adult patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic Read More →
Inogen reports huge increase in net income
Earnings, Health Care & Life Science, Latest news, Technology, Tri-County Public CompaniesInogen, a maker of portable oxygen concentrators based in Goleta, announced a 77 percent increase in net income Feb. 28 on fourth quarter revenues of $50.9 million. Sales revenues grew 47.2 percent over the same quarter in 2015, to $42.6 million. Net income for the quarter was $5.3 million, bringing the company up to $20.5 Read More →
